A group sequential test for treatment effect based on the Fine–Gray model
DOI10.1111/BIOM.12871zbMATH Open1414.62460OpenAlexW2793585079WikidataQ52726861 ScholiaQ52726861MaRDI QIDQ4628366FDOQ4628366
Brent R. Logan, Michael J. Martens
Publication date: 13 March 2019
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc6146968
group sequential designgraft versus host diseasehematopoietic cell transplantationcompeting risks analysisFine-Gray regression model
General nonlinear regression (62J02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Cited In (3)
- Sequential trials in the context of competing risks: concepts and case study, with R and SAS code
- A unified approach to sample size and power determination for testing parameters in generalized linear and time-to-event regression models
- Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point
This page was built for publication: A group sequential test for treatment effect based on the Fine–Gray model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4628366)